Prime editing is an advanced gene editing technology that enables precise DNA corrections without introducing double-stranded breaks, significantly reducing off-target effects. This innovation holds ...

Summit Therapeutics (NASDAQ: SMMT) experienced a significant 30% decrease in its stock on Friday, May 30th, closing at $18. This sudden decline came even though the stock had doubled within the ...

FinPrime, a leading global prime brokerage, has been honoured with two prestigious titles at the World Business Outlook ...

The Global CRISPR Market Size is projected to grow at a CAGR of 15.85% from 2026 to 2032, according to a new report published by Verified Market Research®. The report reveals that the market was ...

Colorado's leading premium cannabis brand, has debuted a refreshed brand identity that embodies its quality-obsessed ethos and unwavering commitment to authenticity, creativity, and innovation through ...

Continuity Biosciences, LLC, a developer of advanced drug delivery technologies, announced today the acquisition of Focal ...

HPE has benefited from a surge in spending on advanced data center architecture, designed to support the complex processing ...

Angelman syndrome is a rare neurogenetic disorder affecting approximately 1 in 15,000 live births or 500,000 people globally. It results from the loss of function of the UBE3A gene located on the 15th ...

Digital Pathology–Based Multimodal Artificial Intelligence Scores and Outcomes in a Randomized Phase III Trial in Men With Nonmetastatic Castration-Resistant Prostate Cancer FGFR2b protein ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...